These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 606421)

  • 1. Oral 1alpha-hydroxyvitamin D3 in the treatment of osteomalacia associated with malabsorption.
    Compston JE; Horton LW; Tighe JR
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():245s-246s. PubMed ID: 606421
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of osteomalacia with oral 1-alpha-hydroxyvitamin D3 in a patient with malabsorption.
    Compston JE; Horton LW; Tighe JR
    Br Med J; 1977 Sep; 2(6087):612. PubMed ID: 902001
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of bone disease after jejunoileal bypass for obesity with oral 1 alpha-hydroxyvitamin D3.
    Compston JE; Horton LW; Laker MF; Merrett AL; Woodhead JS; Gazet JC; Pilkington TR
    Gut; 1980 Aug; 21(8):669-74. PubMed ID: 7429331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D resistant hypophosphataemic osteomalacia: treatment with 1alpha-hydroxyvitamin D3.
    Peacock M; Heyburn PJ; Aaron JE
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():231s-237s. PubMed ID: 203418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1alpha-hydroxyvitamin D3 in the treatment of nutritional and metabolic rickets and osteomalacia.
    Gertner JM; Brenton DB; Edwards RH
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():239s-244s. PubMed ID: 203419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteomalacia and celiac disease: response to 25-hydroxyvitamin D.
    Hepner GW; Jowsey J; Arnaud C; Gordon S; Black J; Roginsky M; Moo HF; Young JF
    Am J Med; 1978 Dec; 65(6):1015-20. PubMed ID: 742623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1 alpha-hydroxyvitamin D3 in intestinal calcium malabsorption. A pilot study.
    Hylander E; Jarnum S
    Scand J Gastroenterol; 1980; 15(4):443-8. PubMed ID: 7433906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of osteomalacia associated with primary biliary cirrhosis with parenteral vitamin D2 or oral 25-hydroxyvitamin D3.
    Compston JE; Horton LW; Thompson RP
    Gut; 1979 Feb; 20(2):133-6. PubMed ID: 311747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1 alpha-hydroxyvitamin D3 treatment of therapy-resistant symptomatic hypocalcemia in a hypoparathyroid patient with intestinal malabsorption.
    Hylander E; Madsen S
    Acta Med Scand; 1979; 205(7):603-5. PubMed ID: 474189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral 25-hydroxyvitain D3 in treatment of osteomalacia associated with ileal resection and cholestyramine therapy.
    Compston JE; Horton LW
    Gastroenterology; 1978 May; 74(5 Pt 1):900-2. PubMed ID: 640344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypophosphatemic vitamin D-resistant osteomalacia treated with 1 alpha- hydroxyvitamin D3 (Etalpha)].
    Lauridsen UB; Schaffalitzky de Muckadell OB
    Ugeskr Laeger; 1980 Apr; 142(18):1154-5. PubMed ID: 7404688
    [No Abstract]   [Full Text] [Related]  

  • 12. Bone disease and hyperparathyroidism in chronic renal failure: the effect of 1alpha-hydroxyvitamin D3.
    Peacock M; Aaron JE; Walker GS; Davison AM
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():73s-81s. PubMed ID: 606428
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experience in treating metabolic osteopathies with 1 alpha-hydroxyvitamin D3 (oksidevit)].
    Babarykin DA; Reĭsner NA; Riabukha AN; Rozental' RL
    Ter Arkh; 1991; 63(11):113-6. PubMed ID: 1810042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of osteomalacia associated with primary biliary cirrhosis with oral 1-alpha-hydroxy vitamin D3.
    Compston JE; Crowe JP; Horton LW
    Br Med J; 1979 Aug; 2(6185):309. PubMed ID: 476441
    [No Abstract]   [Full Text] [Related]  

  • 15. Osteomalacia after small-intestinal resection.
    Compston JE; Ayers AB; Horton LW; Tighe JR; Creamer B
    Lancet; 1978 Jan; 1(8054):9-12. PubMed ID: 74542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathology of renal osteodystrophy with particular reference to the effects of 1alpha-hydroxyvitamin D3 in patients treated by long-term haemodialysis.
    Ellis HA; Pierides AM; Feest TG; Ward MK; Kerr DN
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():31s-38s. PubMed ID: 606422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of adult patients with osteomalacia to treatment with crystalline 1alpha-hydroxy vitamin D3.
    Bordier P; Pechet MM; Hesse R; Marie P; Rasmussen H
    N Engl J Med; 1974 Oct; 291(17):866-71. PubMed ID: 4415589
    [No Abstract]   [Full Text] [Related]  

  • 18. Bone disease in primary biliary cirrhosis: reversal of osteomalacia with oral 25-hydroxyvitamin D.
    Reed JS; Meredith SC; Nemchausky BA; Rosenberg IH; Boyer JL
    Gastroenterology; 1980 Mar; 78(3):512-7. PubMed ID: 7351289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Action of 1alpha-hydroxy vitamin D3 on calcium absorption and bone resorption in man.
    Peacock M; Gallagher JC; Nordin BE
    Lancet; 1974 Mar; 1(7854):385-89. PubMed ID: 4131034
    [No Abstract]   [Full Text] [Related]  

  • 20. 1alpha-hydroxyvitamin D.
    Brancaccio D; Galmozzi C; Casati S; Ponticelli C
    Lancet; 1978 Jun; 1(8077):1314-5. PubMed ID: 78079
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.